A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior

Eyal Vardy1, J Elliott Robinson2, Chia Li3

  • 1Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), University of North Carolina School of Medicine, Chapel Hill, NC 27514, USA.

Neuron
|May 5, 2015
PubMed
Summary

Researchers developed a novel chemogenetic tool, kappa-opioid receptor-derived DREADD (KORD), activated by salvinorin B. This tool enables remote control of neuronal activity and behavior, offering new possibilities for physiological research.

Related Concept Videos